Senior appointments naturally attract attention. A new CEO, Country Head, General Manager or functional executive may carry significant responsibility for the organisation’s future, and considerable care goes into defining the role, approaching the market and selecting the right person.
The appointment can feel like the completion of an important piece of work.
In practice, it is often the beginning of the next one.
A new leader changes the organisation around them. They bring different experience, create new priorities, make decisions in a different way and often expose capability requirements that were less visible under the previous structure. The question that follows is not simply whether the leader is performing. It is whether the organisation around them enables the work they were appointed to do.
This does not mean building a large team immediately or allowing every new executive to redesign the organisation upon arrival. It means understanding which capability is essential to the mandate, which can develop over time and which should remain where it already sits.
Consider an Australian life sciences company appointing its first United States leader. The initial focus may be on finding someone who understands the market, can represent the organisation credibly and establish an effective local presence.
That appointment cannot be considered entirely in isolation. The person may need access to commercial, medical, regulatory, market access and operational capability. Some of that expertise may remain in Australia or elsewhere in APAC. Some may need to be established in the United States. Some may be accessed through interim, fractional or external arrangements while the local organisation takes shape.
If those choices are left entirely until after the person joins, the new leader may spend a significant part of their first year negotiating the support required to perform the mandate. If the structure is fixed before they arrive, the organisation may remove their ability to shape the team around the market they are expected to build.
The useful position sits between those extremes. The organisation should understand the capability dependencies before the search begins while leaving appropriate scope for the leader to influence how the team is ultimately built.
Dependencies are the functions, expertise and decisions without which the leader cannot make meaningful progress. A United States commercial leader may depend on a clear regulatory pathway, credible market access thinking and access to medical expertise. A new CEO may depend on reliable financial information, defined governance arrangements and functional leaders who can carry execution. A Chief Medical Officer may depend on clinical operations, regulatory affairs and scientific capability around the programme.
These dependencies should influence both the leadership brief and the sequence of later appointments.
For example, an organisation may recruit a Country Head with a mandate to establish and grow the local business. If pricing, reimbursement and regulatory requirements differ materially from the organisation’s home market, the leader’s early success may depend on local specialist insight. The answer may not be to recruit full permanent functions immediately. It may be to introduce targeted fractional capability alongside the leader while the organisation learns which responsibilities need to become permanent.
The point is not to give every senior appointment a larger team. It is to identify the minimum capability required for the mandate to be credible.
A useful framework is to consider what the leader will own, what they will need to influence and what must be delivered by others. Ownership includes the decisions and outcomes for which the leader will be accountable. Influence covers areas where they need to shape decisions but do not carry sole authority. Delivery identifies the capability elsewhere in the organisation on which execution will depend.
A Chief Commercial Officer may own commercial strategy, team development and revenue performance. They may need to influence product positioning, market selection and investment priorities. Delivery may depend on medical, regulatory, market access, supply and operational capability beyond the commercial function.
If those relationships are not clear, expectations can become uneven. The commercial executive may be held accountable for outcomes that rely on work they cannot control. Other functions may experience the new leader as moving beyond their mandate. The resulting tension is often described as a people issue when it is actually a design issue.
The same framework helps when building around a new CEO. The Board may appoint a CEO to take the organisation through commercialisation, international growth or transformation. The person may inherit capable executives who were successful during the previous stage but are now working within substantially changed mandates.
The question should not immediately become who stays and who goes. It is more useful to examine what the new strategy requires from each function, whether the existing capability can meet that requirement and where support, development or different leadership may be needed.
A strong finance leader in an early-stage organisation may need different experience as reporting, capital management and commercial complexity increase. A scientific founder who has carried broad technical responsibility may need specialist leaders around them as programmes expand. An operations leader who succeeded within one market may require regional capability as the organisation enters several.
The fact that a mandate has changed does not automatically mean the person should change. It does mean that experience and readiness should be assessed against the work ahead rather than against past performance alone.
Timing remains important. Some capability must be available when the leader arrives because it is fundamental to the mandate. Some should be shaped with the leader because their judgement is part of the reason they were appointed. Other roles should follow only after early decisions clarify the continuing requirement.
Consider a new CEO joining an investor-backed healthcare company to lead growth and organisational change. They may need a strong finance and operations capability from the outset because reliable information and effective execution are essential to their first decisions. The future commercial or people structure may be better developed after the CEO has assessed the organisation and confirmed the strategy.
The order therefore depends on which capability provides the foundation for the leader’s work and which capability should emerge from it.
This can be considered through three time horizons. The first is capability required on arrival. Without it, the leader’s mandate is immediately constrained. The second is capability required during the first stage of implementation. It becomes necessary as the leader translates direction into action. The third is capability required by the organisation being built. It may not be justified today, but the early decisions should not make it unnecessarily difficult to introduce later.
These horizons help organisations avoid two common problems. The first is leaving the leader unsupported and expecting them to solve every capability gap personally. The second is building a complete future structure before the leader has had an opportunity to understand the organisation and influence its design.
They also make it easier to consider different engagement models. Capability required on arrival may be provided permanently if the need is enduring, through an interim leader if immediate accountability is required, or fractionally if senior expertise is important before the full-time structure is justified. The employment model follows the work and timing rather than determining them.
Building around the leader also affects how the initial opportunity is represented to candidates. Senior people will want to understand not only the role but the organisation they will inherit. They will want to know which capability is already strong, where gaps exist, which appointments they can shape and whether the investment required to build the team is realistic.
A credible discussion about these issues makes the opportunity stronger, not weaker. It shows that the organisation understands the difference between appointing a leader and enabling them to lead.
The same thinking applies below executive level. A newly appointed functional leader may need managers and specialists around them. A market access leader may need health economics or policy capability. A regulatory leader may require regional or product-specific expertise. A digital health leader may depend on clinical, technology, product and commercial contributors who sit across several functions.
Not every requirement will lead to recruitment. Existing people may be developed, responsibilities may be redesigned, external partnerships may provide capability or flexible appointments may bridge the period before a permanent team is justified. The important point is that these choices remain connected to the mandate rather than emerging as a series of unrelated vacancies.
One appointment can create momentum, but it can also reveal the limits of the organisation around it. That is not evidence that the original search was incomplete. It is often a natural consequence of introducing new leadership into a business that is growing or changing.
The strongest organisations anticipate that possibility. They identify the capability dependencies, understand which decisions the leader should shape and retain enough flexibility to build the team in the right order.
The leader matters. The capability around them often determines how much of that leadership the organisation can actually use.
Appoint the leader. Build the team.
You may be appointing a CEO, Country Head or functional leader, or considering the leadership and specialist capability that will be required around someone already in place. Hunton Executive can help you connect the initial appointment to the team, structure and capability the organisation will need next.
About Hunton Executive
Executive search, strategic headhunting, and specialist recruitment for healthcare and life sciences organisations. From Board appointments and executive leadership to the specialist capability around them. Permanent, interim and fractional.